Harprit S Pannu

Title: Harprit S Pannu: Innovator in Receptor Tyrosine Kinase Pathway Analysis

Introduction

Harprit S Pannu is a notable inventor based in San Jose, California. He has made significant contributions to the field of biotechnology, particularly in the analysis of receptor tyrosine kinase (RTK) signaling pathways. His innovative work has implications for both diagnosis and therapy in various medical conditions.

Latest Patents

Harprit S Pannu holds a patent for a method that determines the activation status of receptor tyrosine kinase pathways in cell or patient samples. This invention focuses on measuring receptor dimerization and the relative amounts of protein-protein complexes or activated effector proteins characteristic of an RTK pathway. The method aids in selecting patients who are responsive to pathway-specific drugs, particularly those related to ErbB receptors. The invention utilizes sets of binding compounds with releasable molecular tags specific for multiple components involved in RTK activation. After binding, these molecular tags are released and separated for analysis.

Career Highlights

Harprit S Pannu is associated with Monogram Biosciences, Inc., where he continues to advance his research and innovations. His work is pivotal in enhancing the understanding of RTK pathways and their role in targeted therapies.

Collaborations

Harprit collaborates with talented individuals such as Ali Mukherjeei and Mengxiang Tang, contributing to a dynamic research environment that fosters innovation.

Conclusion

Harprit S Pannu's contributions to receptor tyrosine kinase pathway analysis exemplify the intersection of innovation and healthcare. His work not only advances scientific understanding but also has the potential to improve patient outcomes through targeted therapies.